Metageria

From WikiMD's WELLNESSPEDIA


Metageria
Synonyms Progeroid syndrome
Pronounce N/A
Specialty N/A
Symptoms Premature aging, wrinkled skin, hair loss, osteoporosis, atherosclerosis
Complications N/A
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Increased risk of cardiovascular disease, stroke, heart attack
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis N/A
Prevention N/A
Treatment Symptomatic management, physical therapy, nutritional support
Medication N/A
Prognosis Variable, often reduced lifespan
Frequency Rare
Deaths N/A


Metageria is a rare, genetic, metabolic disorder characterized by early childhood onset of neurodegeneration, dysphagia, ataxia, and intellectual disability, associated with progressive psychomotor regression, seizures, autonomic dysfunction and movement disorders.

Clinical Description[edit]

Patients with Metageria typically present in early childhood with dysphagia, ataxia, and intellectual disability. As the disease progresses, patients may develop seizures, autonomic dysfunction, and movement disorders. The disease is progressive and often leads to severe neurodegeneration.

Etiology[edit]

Metageria is caused by mutations in the MEGF10 gene. This gene provides instructions for making a protein that is involved in the process of autophagy, which is the body's way of cleaning out damaged cells, in order to regenerate newer, healthier cells.

Diagnosis[edit]

Diagnosis of Metageria is based on clinical symptoms and confirmed by genetic testing showing mutations in the MEGF10 gene.

Treatment[edit]

There is currently no cure for Metageria. Treatment is supportive and aimed at managing symptoms.

Prognosis[edit]

The prognosis for individuals with Metageria is poor. The disease is progressive and often leads to severe neurodegeneration.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.